MedTrace Logo

Development of a Youth Healthy Living Program With Underserved Adolescents at Rochester Alternative Learning Center

NCT02289313 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 48

Last updated 2021-12-16

No results posted yet for this study

Summary

Approximately one third of the children and adolescents in the United States are either overweight or obese. Childhood obesity disproportionately affects specific racial and ethnic groups and households with low socioeconomic status and low parental education. The Alternative Learning Center (ALC) within Rochester School District 535 provides viable educational options for students who are experiencing difficulty in regular educational systems. A greater proportion of students at ALC are minorities, qualify for free and reduced lunch and receive special education services. These children are likely to have unique barriers to physical activity and healthy eating.

Specific Aims:

Aim 1: Examine the association between BMI and ethnic/ socioeconomic variables and behaviors related to physical activity and eating in ALC students.

Aim 2: Develop an age and culturally appropriate on-site program that promotes healthy lifestyle.

Conditions

  • Childhood Obesity

Interventions

BEHAVIORAL

Healthy Youth Living Program

Physical activity and healthy eating program at the Alternative Learning Center co-developed by students, school staff and academic partners.

Sponsors & Collaborators

  • Rochester Alternative Learning Center

    collaborator UNKNOWN

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Seema Kumar, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
12 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-11-30
Primary Completion
2015-03-06
Completion
2015-06-17

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02289313 on ClinicalTrials.gov